
Alert: Rating Upgrade (3/18/24)-CASI Pharmaceuticals Inc (NASDAQ: CASI).
Stock Rating Upgrade The Value Trend Rating for CASI Pharmaceuticals Inc (NASDAQ: CASI) improved in recent days from C to B reflecting improving fundamentals and high Appreciation Potential. Details supporting this higher rating are included […]